DFT Calculations and In silico Study of Chlorogenic, Ellagic and Quisqualic acids as Potential Inhibitors of SARS-CoV-2 Main Protease Mpro

被引:5
|
作者
Shahab, Siyamak [1 ,2 ,3 ]
Kaviani, Sadegh [4 ]
Sheikhi, Masoome [5 ]
Almodarresiyeh, Hora Alhosseini [6 ]
Al Saud, Sultan [1 ,3 ]
机构
[1] Belarusian State Univ, ISEI BSU, Minsk, BELARUS
[2] Natl Acad Sci Belarus, Inst Phys Organ Chem, 13 Surganov Str, Minsk 220072, BELARUS
[3] Natl Acad Sci Belarus, Inst Chem New Mat, 36 Skarina Str, Minsk 220141, BELARUS
[4] Ferdowsi Univ Mashhad, Fac Sci, Dept Chem, Mashhad, Razavi Khorasan, Iran
[5] Islamic Azad Univ, Gorgan Branch, Young Researchers & Elite Club, Gorgan, Golestan, Iran
[6] Meybod Univ, Sch Engn, Dept Mat Sci & Engn, Meybod 8961699557, Yazd, Iran
来源
关键词
SARS-CoV-2 main protease M-pro; DFT; molecular docking; chlorogenic; Ellagic and Quisqualic acids; pharmacokinetic properties; COFFEE; METABOLITES; DERIVATIVES; DISCOVERY; TRANSPORT; UV/VIS; HUMANS;
D O I
10.33263/BRIAC121.061073
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
In the present work, at first, density functional theory calculations were performed to investigate the molecular structure of the Chlorogenic, Ellagic, and Quisqualic acids by CAM-B3LYP/MidiX level of theory. A detail of quantum molecular descriptors of the title compounds such as ionization potential (IP) and Electron Affinities (EA), Hardness (eta), Softness (S), Electronegativity (mu), Electrophilic Index (omega), Electron Donating Power (omega-), Electron Accepting Power (omega+) and Energy Gap (Eg) have been calculated. Pharmacokinetic properties of the title compounds and their bioactivity were investigated. In the following, a molecular docking study was carried out to screen for an effective available compound that may work as a strong inhibitor for the SARS-CoV-2 main protease Mpro. The binding energy between SARS-CoV-2 main protease Mpro and title organic acids showed a good binding affinity. Therefore, the Chlorogenic, Ellagic, and Quisqualic acids can be used for potential application against the SARS-CoV-2 main protease Mpro.
引用
收藏
页码:61 / 73
页数:13
相关论文
共 50 条
  • [11] Autochthonous Peruvian Natural Plants as Potential SARS-CoV-2 Mpro Main Protease Inhibitors
    Peralta-Moreno, Maria Nuria
    Anton-Munoz, Vanessa
    Ortega-Alarcon, David
    Jimenez-Alesanco, Ana
    Vega, Sonia
    Abian, Olga
    Velazquez-Campoy, Adrian
    Thomson, Timothy M.
    Granadino-Roldan, Jose Manuel
    Machicado, Claudia
    Rubio-Martinez, Jaime
    [J]. PHARMACEUTICALS, 2023, 16 (04)
  • [12] A Multistage In Silico Study of Natural Potential Inhibitors Targeting SARS-CoV-2 Main Protease
    Elkaeed, Eslam B.
    Eissa, Ibrahim H.
    Elkady, Hazem
    Abdelalim, Ahmed
    Alqaisi, Ahmad M.
    Alsfouk, Aisha A.
    Elwan, Alaa
    Metwaly, Ahmed M.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (15)
  • [13] IN SILICO PREDICTION OF INHIBITORY POTENTIAL OF A PUNICALAGIN ß-ANOMER AGAINST SARS-COV-2 MAIN PROTEASE (MPRO)
    Monteiro, Norberto
    Monteiro, Vitoria
    Lima, Lorena
    Karolline, Anna
    Machado, Richele
    [J]. QUIMICA NOVA, 2022, 45 (10): : 1230 - 1235
  • [14] Natural compounds as potential inhibitors of SARS-CoV-2 main protease: An in-silico study
    Mishra, Amaresh
    Pathak, Yamini
    Kumar, Anuj
    Mishra, Surabhi Kirti
    Tripathi, Vishwas
    [J]. ASIAN PACIFIC JOURNAL OF TROPICAL BIOMEDICINE, 2021, 11 (04) : 155 - 163
  • [15] Evaluation of Xa inhibitors as potential inhibitors of the SARS-CoV-2 Mpro protease
    Papaj, Katarzyna
    Spychalska, Patrycja
    Kapica, Patryk
    Fischer, Andre
    Nowak, Jakub
    Bzowka, Maria
    Sellner, Manuel
    Lill, Markus A.
    Smiesko, Martin
    Gora, Artur
    [J]. PLOS ONE, 2022, 17 (01):
  • [16] In silico investigation of HCV and RNA synthesis inhibitor antibiotic drugs as potential inhibitors of SARS-CoV-2 main protease (Mpro)
    Kishore, Merusomayajula V.
    Rao, T. Siva
    Kumari, G. N. D.
    [J]. FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 10 (01)
  • [17] Progress in Research on Inhibitors Targeting SARS-CoV-2 Main Protease (Mpro)
    Yang, Yue
    Luo, Yi-Dan
    Zhang, Chen-Bo
    Xiang, Yang
    Bai, Xin-Yue
    Zhang, Die
    Fu, Zhao-Ying
    Hao, Ruo-Bing
    Liu, Xiao-Long
    [J]. ACS OMEGA, 2024, 9 (32): : 34196 - 34219
  • [18] Potential SARS-CoV-2 main protease inhibitors
    Banerjee, Riddhidev
    Perera, Lalith
    Tillekeratne, L. M. Viranga
    [J]. DRUG DISCOVERY TODAY, 2021, 26 (03) : 804 - 816
  • [19] In silico analysis of selected alkaloids against main protease (Mpro) of SARS-CoV-2
    Garg, Saksham
    Roy, Arpita
    [J]. CHEMICO-BIOLOGICAL INTERACTIONS, 2020, 332
  • [20] In-silico drug repurposing for targeting SARS-CoV-2 main protease (Mpro)
    Sharma, Shilpa
    Deep, Shashank
    [J]. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (07): : 3003 - 3010